189 related articles for article (PubMed ID: 32972546)
1. Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.
Donnellan E; Wazni OM; Hanna M; Elshazly MB; Puri R; Saliba W; Kanj M; Vakamudi S; Patel DR; Baranowski B; Cantillon D; Dresing T; Jaber WA
JACC Clin Electrophysiol; 2020 Sep; 6(9):1118-1127. PubMed ID: 32972546
[TBL] [Abstract][Full Text] [Related]
2. Atrial electrofunctional predictors of incident atrial fibrillation in cardiac amyloidosis.
Sinigiani G; De Michieli L; Porcari A; Zocchi C; Sorella A; Mazzoni C; Bisaccia G; De Luca A; Di Bella G; Gregori D; Perfetto F; Merlo M; Sinagra G; Iliceto S; Perazzolo Marra M; Corrado D; Ricci F; Cappelli F; Cipriani A
Heart Rhythm; 2024 Jun; 21(6):725-732. PubMed ID: 38309449
[TBL] [Abstract][Full Text] [Related]
3. Systemic embolism in amyloid transthyretin cardiomyopathy.
Vilches S; Fontana M; Gonzalez-Lopez E; Mitrani L; Saturi G; Renju M; Griffin JM; Caponetti A; Gnanasampanthan S; De Los Santos J; Gagliardi C; Rivas A; Dominguez F; Longhi S; Rapezzi C; Maurer MS; Gillmore J; Garcia-Pavia P
Eur J Heart Fail; 2022 Aug; 24(8):1387-1396. PubMed ID: 35650018
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation in the setting of cardiac amyloidosis - A review of the literature.
Bazoukis G; Saplaouras A; Efthymiou P; Yiannikourides A; Liu T; Sfairopoulos D; Korantzopoulos P; Varrias D; Letsas KP; Thomopoulos C; Tse G; Stavrakis S
J Cardiol; 2024 Mar; ():. PubMed ID: 38565394
[TBL] [Abstract][Full Text] [Related]
5. Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality.
Maury P; Sanchis K; Djouadi K; Cariou E; Delasnerie H; Boveda S; Fournier P; Itier R; Mondoly P; Voglimacci-Stephanopoli Q; Beneyto M; Dhanjal TS; Rollin A; Damy T; Lairez O; Lellouche N
PLoS One; 2024; 19(4):e0301753. PubMed ID: 38578782
[TBL] [Abstract][Full Text] [Related]
6. Temporal Outcomes of Patients Diagnosed With Transthyretin Cardiac Amyloidosis.
Chan N; Teruya S; Mirabal A; Weinsaft AY; Santos JL; Guadalupe S; Jimenez M; Rodriguez C; Helmke S; Cuomo M; Smiley D; Maurer MS
J Card Fail; 2024 Mar; ():. PubMed ID: 38458484
[TBL] [Abstract][Full Text] [Related]
7. Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study.
Fumagalli C; Ponti L; Smorti M; Pozza F; Argirò A; Zampieri M; Di Mario C; Marfella R; Sardu C; Paolisso G; Olivotto I; Perfetto F; Ungar A; Marchionni N; Cappelli F
Aging Clin Exp Res; 2024 Apr; 36(1):89. PubMed ID: 38598143
[TBL] [Abstract][Full Text] [Related]
8. The Prevalence of Advanced Interatrial Block and Its Relationship to Left Atrial Function in Patients with Transthyretin Cardiac Amyloidosis.
Lindow T; Lindqvist P
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34201866
[TBL] [Abstract][Full Text] [Related]
9. Clinical clues for suspecting wild-type transthyretin cardiac amyloidosis in patients with monoclonal gammopathy of undetermined significance: a case report.
Haga T; Okumura T; Harada Y; Hiraiwa H; Morimoto R; Kaneko S; Kato N; Shinoda M; Murohara T
Egypt Heart J; 2024 Jun; 76(1):74. PubMed ID: 38856864
[TBL] [Abstract][Full Text] [Related]
10. Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real-World Data.
Müller ML; Latinova E; Brand A; Mattig I; Spethmann S; Messroghli D; Hahn K; Landmesser U; Heidecker B
J Am Heart Assoc; 2024 Jul; ():e033478. PubMed ID: 38958150
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial Fibrillation.
Yamasaki H; Kondo H; Shiroo T; Iwata N; Masuda T; Makita T; Iwabuchi Y; Tanazawa K; Takahashi M; Ono Y; Ogawa N; Harada T; Mitarai K; Yamauchi S; Takano M; Kodama N; Hirota K; Miyoshi M; Yonezu K; Tawara K; Abe I; Saito S; Fukui A; Fukuda T; Akioka H; Shinohara T; Akiyoshi K; Teshima Y; Yufu K; Daa T; Matsubara E; Asayama Y; Ueda M; Takahashi N
Circ J; 2024 Jun; 88(7):1167-1175. PubMed ID: 38522901
[TBL] [Abstract][Full Text] [Related]
12. Clinical and imaging characteristics of patients with cardiac amyloidosis- a single center observational study.
Ingebrigtsen A; Saeed S; Larsen TH; Reikvam H
Scand J Clin Lab Invest; 2024 May; 84(3):193-201. PubMed ID: 38709651
[TBL] [Abstract][Full Text] [Related]
13. Cryptogenic ischemic stroke in cardiac transthyretin amyloidosis and sinus rhythm: a case report.
Napolitano A; Toffanin S; Bulato C; Campello E; Simioni P; Spiezia L
Front Cardiovasc Med; 2024; 11():1386733. PubMed ID: 38803660
[TBL] [Abstract][Full Text] [Related]
14. Predictors of developing renal dysfunction following diagnosis of transthyretin cardiac amyloidosis.
McDonald ML; Manla Y; Sonnino A; Alonso M; Neicheril RK; Sanchez A; Lafave G; Armas YS; Camargo AL; Uppal D; Handa A; Wolinsky D; Rivera NT; Velez M; Baran DA; Estep JD; Snipelisky D
Clin Cardiol; 2024 Jun; 47(6):e24298. PubMed ID: 38873847
[TBL] [Abstract][Full Text] [Related]
15. Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates.
Aquaro GD; Morini S; Grigoratos C; Taborchi G; Di Bella G; Martone R; Vignini E; Emdin M; Olivotto I; Perfetto F; Cappelli F
Int J Cardiol Heart Vasc; 2020 Dec; 31():100633. PubMed ID: 32995476
[TBL] [Abstract][Full Text] [Related]
16. Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network.
Choy CH; Steeds RP; Pinney J; Baig S; Turvey-Haigh L; Wahid Y; Cox H; Zaphiriou A; Srinivasan V; Wilson D; Fryearson J; Ahamed M; Lim S; Chue C; Pratt G; Fontana M; Gillmore JD; Moody WE
Clin Med (Lond); 2024 Jan; 24(1):100004. PubMed ID: 38377730
[TBL] [Abstract][Full Text] [Related]
17. Sex Differences in Transthyretin Cardiac Amyloidosis: Unraveling the Complexities in Epidemiology, Pathophysiology, Diagnosis, and Treatment.
Vilches S; Martínez-Avial M; Méndez I; Gómez González C; Espinosa MÁ
Curr Heart Fail Rep; 2024 May; ():. PubMed ID: 38775878
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation in Atrial Fibrillation Associated With Cardiac Amyloidosis: A Narrative Review.
Monga TS; Ekong M; Patrick K; Bommana Boyena TG; Ravanam AS; Vargas S; Mavus NB; Lakshmi AP; Singh K; Vegesna RR; Abbas K
Cureus; 2024 Jun; 16(6):e61557. PubMed ID: 38962633
[TBL] [Abstract][Full Text] [Related]
19. Race, Genotype, and Prognosis in Black Patients With Transthyretin Cardiac Amyloidosis.
Khedraki R; Saef J; Martens P; Martyn T; Sul L; Hachamovitch R; Ives L; Estep JD; Tang WHW; Hanna M
Am J Cardiol; 2024 Apr; 216():66-76. PubMed ID: 38278432
[TBL] [Abstract][Full Text] [Related]
20. Current Therapies and Future Horizons in Cardiac Amyloidosis Treatment.
Vogel J; Carpinteiro A; Luedike P; Buehning F; Wernhart S; Rassaf T; Michel L
Curr Heart Fail Rep; 2024 May; ():. PubMed ID: 38809394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
